MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 47 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 61.00 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,928,752 | $12,383,000 | 1.63% |
| ACUTA CAPITAL PARTNERS, LLC | 380,000 | $2,440,000 | 1.14% |
| Lion Point Capital, LP | 683,570 | $4,388,000 | 1.02% |
| Novo Holdings A/S | 2,530,003 | $16,243,000 | 0.86% |
| Boxer Capital, LLC | 2,238,861 | $14,373,000 | 0.74% |
| RTW INVESTMENTS, LP | 4,315,102 | $27,703,000 | 0.57% |
| RA Capital Management | 2,246,503 | $14,423,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,605,000 | 0.28% |
| Orbimed Advisors | 2,583,821 | $16,588,000 | 0.27% |
| PURA VIDA INVESTMENTS, LLC | 987,411 | $6,339,000 | 0.21% |